Evidence map›Paper›PMID 40092514›Full record

ArticleIJTLD open2025

Investigating low uptake of tuberculin skin testing when integrated with active case-finding for TB.

T S Johnson, A Nalutaaya, P Biché, K Ndyabayunga, R Okura, I Mugabi, D Nantale, V Nakiiza, P J Kitonsa, E A Kendall and 2 more

Abstract read
In one paragraph

Article in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

T S JohnsonJohns Hopkins Bloomberg School of Public Health, Epidemiology, Baltimore, MD, USA.
A NalutaayaWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
P BichéJohns Hopkins Bloomberg School of Public Health, Epidemiology, Baltimore, MD, USA.
K NdyabayungaWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
R OkuraWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
I MugabiWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
D NantaleWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
V NakiizaWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
P J KitonsaWalimu, Uganda Tuberculosis Implementation Research Consortium. Kampala, Uganda.
E A KendallJohns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD, USA.
A KatambaMakerere University College of Health Sciences, Department of Internal Medicine, Clinical Epidemiology and Biostatics Unit, Kampala, Uganda.
D W DowdyJohns Hopkins Bloomberg School of Public Health, Epidemiology, Baltimore, MD, USA.

Funding

Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trialR01HL138728 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI David Wesley Dowdy, Emily A Kendall · 2017 to 2026
$5.4M
NHLBI NIH HHS R01 HL138728
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diagnosisepidemiologyprevention/control programTBItuberculosis

Identifiers

PMID40092514
PMCPMC11906024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.